A- A A+

Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys. 

Carlisle VR, Maynard OM, Bagnall D, Hickman M, Shorrock J, Thomas K, Kesten J. 

International Journal of Environmental Research and Public Health. 2023; 20(2):1526. doi.org/10.3390/ijerph20021526


USA. Hospitals look to storytelling to reduce stigma toward people with addiction 

(…) Most health care professionals hold negative attitudes toward patients with substance use disorders, according to a 2013 systematic review of more than two dozen studies. These attitudes can result in patients receiving suboptimal care. (…)

Throughout society, stigma continues to surround people living with addiction. Experts say in order to combat the opioid crisis, there needs to be greater societal understanding about addiction and more empathy toward people with substance use disorders. 

One strategy, spearheaded by researchers in the Midwest, involves using personal narratives to address stigma and biases held by medical professionals. (WBAA, USA, 05.01.2023)


Addressing Stigma is Not Enough. 

Amon JJ, Sun N, Iovita A, Jurgens R, Csete J. 

Health Hum Rights. 2022 Dec;24(2):111-114. PMID: 36579301; PMCID: PMC9790942.


Temporal associations between depressive features and self-stigma in people with substance use disorders related to heroin, amphetamine, and alcohol use: a cross-lagged analysis. 

Saffari M, Chang KC, Chen JS, Chang CW, Chen IH, Huang SW, Liu CH, Lin CY, Potenza MN. 

BMC Psychiatry. 2022 Dec 21;22(1):815. doi: 10.1186/s12888-022-04468-z. PMID: 36544132; PMCID: PMC9768939.


Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study. 

Tran HV, Filipowicz TR, Landrum KR, Nong HTT, Tran TTT, Pence BW, Go VF, Le GM, Nguyen MX, Verhey R, Chibanda D, Ho HT, Gaynes BN. 

AIDS Res Ther. 2022 Dec 14;19(1):63. doi: 10.1186/s12981-022-00491-y. PMID: 36517849; PMCID: PMC9753276.


Comparisons of psychological distress and self-stigma among three types of substance use disorders receiving treatment-as-usual approaches: real-world data from a 9-month longitudinal study.

Chang KC, Chen HP, Huang SW, Chen JS, Potenza MN, Pakpour AH, Lin CY. 

Ther Adv Chronic Dis. 2022 Dec 2;13:20406223221140393. doi: 10.1177/20406223221140393. PMID: 36483780; PMCID: PMC9723802.


The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting. 

Bardwell G, Mansoor M, Van Zwietering A, Cleveland E, Snell D, Kerr T. 

Harm Reduct J. 2022 Dec 7;19(1):136. doi: 10.1186/s12954-022-00725-2. PMID: 36476225; PMCID: PMC9730691.


Time to Stop Using the Word “Smoker”: Reflecting on the Role of Language in Advancing the Field of Nicotine and Tobacco Research,

Renee D Goodwin, PhD, MPH, Lisa K Walker, PhD, 

Nicotine & Tobacco Research, 2022;, ntac218,  doi.org/10.1093/ntr/ntac218


UK. Stigma Kills - See the person. Hear their story.

Everyone knows someone who experiences addiction.

We all know someone who has experienced addiction at some point in their lives, from substance misuse to gambling or gaming addiction.

Although addiction is a common health issue that requires medical intervention and support, people suffering from this illness are some of the most stigmatised in society, often seen as not even unwell and in some way deserving of their experiences. (NHS – National Health Service, Addictions Provider Alliance, UK, November 2022)


Psychische Erkrankungen: Maßnahmen gegen Stigmatisierung angeraten 

London – Soziale Kontakte zwischen Menschen mit und ohne Erfahrungen mit psychischen Erkrankungen sind der wirksamste Weg, um Stigmatisierung und Diskriminierung bei psychischen Krankheiten zu verringern. Das berichtet eine neue internationale Kommission des Fachmagazins Lancet (DOI: 10.1016/S0140-6736(22)01470-2). (aerzteblatt.de, 18.10.2022)


So many harms, so little benefit: a global review of the history and harms of HIV criminalisation

Csete, Joanne et al.

The Lancet HIV, Volume 0, Issue 0 


HIV/AIDS Language Compendium of internationally agreed terms, concepts, definitions and evidence for rights-based responses

(Love Alliance, HIV Policy Lab, O’Neill Institute for National & Global Health Law, 2022)


The Lancet Commission on ending stigma and discrimination in mental health

Thornicroft, Graham et al.

The Lancet, Volume 400, Issue 10361, 1438 - 1480 


Kanada. New tools aim to improve care for people experiencing substance use stigma

Stigma and discrimination associated with substance use, known as substance use stigma, contribute directly to significant harms and barriers to care. Due to widespread negative attitudes towards substance use issues, people are often treated in disrespectful or discriminatory ways in health care settings.

Now a team of researchers at UBC and Western University are offering a suite of tools and strategies to ensure that people who experience substance use stigma can receive better care in the future. (UBC – University of British Columbia, Kanada, 20.09.2022)


Understanding the Association between Alcohol Stigma and Alcohol Consumption within Europe: A Cross-Sectional Exploratory Study. 

Kummetat JL, Leonhard A, Manthey J, Speerforck S, Schomerus G. 

Eur Addict Res. 2022 Sep 9:1-9. doi: 10.1159/000526200. Epub ahead of print. PMID: 36088900.


USA. Rahul Gupta, first physician to serve as drug czar, says stigma among doctors is key culprit in addiction crisis

(…) Gupta’s selection as director of the White House Office of National Drug Control Policy, however, has ushered in a new era of federal drug policy. As the first doctor to hold the position, he says he will embrace new strategies, including harm reduction tactics, which aim to reduce drug users’ risk of overdose, death, and disease in lieu of a hardline, abstinence-only attitude. (…)

We have, obviously, stigma that prevents so many people from asking for help and others for providing the help. It’s both — in communities, but also in health care. The stigma in my own profession is no less than what we see in communities and individuals. (STAT, USA, 02.09.2022)




Transgender people experience social and cultural stigma and discrimination [1, 2]. This includes discrimination in education, employment and the provision of goods and services, including health care, as well as harassment, violence and exploitation. Transgender people are also disproportionately affected by harmful and discriminatory criminal laws. These multiple and intersecting forms of discrimination result in social and economic inequality, poverty, exclusion and isolation. Evidence indicates that such marginalization, criminalization and discrimination can lead to greater vulnerability to and risk of long-term mental and physical health issues, including increased risk of HIV [3–5]. (UNODC, UNAIDS, WHO, UNDP, Penal Reform International, 2022)


Constructing a 'target population': A critical analysis of public health discourse on substance use among gay and bisexual men, 2000-2020. 

Schroeder SE, Bourne A, Doyle JS, Hellard ME, Stoové M, Pedrana A. 

Int J Drug Policy. 2022 Jul 29;108:103808. doi: 10.1016/j.drugpo.2022.103808. Epub ahead of print. PMID: 35914477.


Australien. The stigma of long-term methadone treatment (Audio)

People in treatment programs for opiates face considerable stigma.

We hear from a woman with lived experience of addiction, treatment and stigma, and an expert on what best practice looks like for opiate treatment in Australia. (ABC radio Network, Australien, 15.08.2022, Audio, 09:45)


Frameworks and measures for HIV-related internalized stigma, stigma and discrimination in healthcare and in laws and policies: a systematic review. 

Ferguson L, Gruskin S, Bolshakova M, Yagyu S, Fu N, Cabrera N, Rozelle M, Kasoka K, Oraro-Lawrence T, Stackpool-Moore L, Motala A, Hempel S. 

J Int AIDS Soc. 2022 Jul;25 Suppl 1(Suppl 1):e25915. doi: 10.1002/jia2.25915. PMID: 35818866; PMCID: PMC9274352.


Does Online Newsmedia Portrayal of Substance Use and Persons with Substance Misuse Endorse Stigma? A Qualitative Study from India. 

Ghosh A, Naskar C, Sharma N, Fazl-E-Roub, Choudhury S, Basu A, Pillai RR, Basu D, Mattoo SK. 

Int J Ment Health Addict. 2022 Jun 24:1-19. doi: 10.1007/s11469-022-00859-1. Epub ahead of print. PMID: 35789814; PMCID: PMC9243953.


HIV Related Stigma among Healthcare Providers: Opportunities for Education and Training. 

Spence AB, Wang C, Michel K, Ocampo JM, Kharfen M, Merenstein D, Goparaju L, Kassaye S. 

J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221114797. doi: 10.1177/23259582221114797. PMID: 35850610; PMCID: PMC9310064.


Changes in Attitudes toward People with Substance Use Disorder: A Comparative Study of the General Population in Mexico. 

Bustos-Gamiño M, Mora-Ríos J, Villatoro-Velázquez J, Fleiz-Bautista C, Molina-López A, Medina-Mora ME. 

Int J Environ Res Public Health. 2022 Jul 13;19(14):8538. doi: 10.3390/ijerph19148538. PMID: 35886390; PMCID: PMC9316581.


Public stigma of opioid addiction: Is opioid use disorder really a medical illness?

Public stigma of opioid addiction can affect opioid use disorder service availability and access, as well as the mental health and well-being of persons with an opioid use disorder. To further understand opportunities to enhance support for an empirically-supported, public health approach to opioid use disorder, this study reports on the public’s attitudes toward opioid addiction in a statewide survey of adults in Pennsylvania. (Recovery Research Institute, USA, Juli 2022)


"You're Not Supposed to be on it Forever": Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids. 

Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Green Montaque HD. 

Subst Abuse. 2022 Jun 27;16:11782218221103859. doi: 10.1177/11782218221103859. PMID: 35783464; PMCID: PMC9243471.


Parents of adult children with drug addiction dealing with shame and courtesy stigma

Olivia Liahaugen Flensburg, Torkel Richert & Marie Väfors Fritz (2022)

Drugs: Education, Prevention and Policy, DOI: 10.1080/09687637.2022.2099249


Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot. 

Treloar C, Lancaster K, Gendera S, Rhodes T, Shahbazi J, Byrne M, Degenhardt L, Farrell M. 

Int J Drug Policy. 2022 Jul 8;107:103788. doi: 10.1016/j.drugpo.2022.103788. Epub ahead of print. PMID: 35816790.


Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey. 

Lin Q, Kolak M, Watts B, Anselin L, Pollack H, Schneider J, Taylor B. 

Soc Sci Med. 2022 Jul;305:115034. doi: 10.1016/j.socscimed.2022.115034. Epub 2022 May 14. PMID: 35636049.


Language Matters: Is This a Drug Overdose or Drug Poisoning Crisis?

In public policy, language matters. In drug policy, language has always been divisive. Words from “dealer” to “addict” have been used to marginalise, incarcerate, and strip three-dimensional humanity away from people by casting them as two-dimensional villains. (TalkingDrugs, UK, 09.06.2022)


Course and Correlates of Stigma in Patients on Opioid Agonist Treatment: A Prospective Study from an Outpatient Treatment Program in India. 

Ghosh A, Roub F, Pillai RR, Mahintamani T, Basu D, Subodh BN, Mattoo SK. 

Indian J Psychol Med. 2022 May;44(3):246-252. doi: 10.1177/02537176211012103. Epub 2021 Jun 14. PMID: 35656428; PMCID: PMC9125463.